Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Effects of Supplemental Calcium and Vitamin D on Expression of Toll-Like Receptors and Phospho-IKKα/β in the Normal Rectal Mucosa of Colorectal Adenoma Patients.

Hodge R, Mandle HB, Ray S, Tandon S, Peterson M, Henry A, Jahan FA, Bostick RM, Baron JA, Barry EL, Yacoub R, Rutherford RE, Seabrook ME, Fedirko V.

Cancer Prev Res (Phila). 2018 Nov;11(11):707-716. doi: 10.1158/1940-6207.CAPR-18-0123. Epub 2018 Sep 12.

PMID:
30209117
2.

Effects of supplemental calcium and vitamin D on the APC/β-catenin pathway in the normal colorectal mucosa of colorectal adenoma patients.

Liu S, Barry EL, Baron JA, Rutherford RE, Seabrook ME, Bostick RM.

Mol Carcinog. 2017 Feb;56(2):412-424. doi: 10.1002/mc.22504. Epub 2016 Jun 14.

3.

A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas.

Baron JA, Barry EL, Mott LA, Rees JR, Sandler RS, Snover DC, Bostick RM, Ivanova A, Cole BF, Ahnen DJ, Beck GJ, Bresalier RS, Burke CA, Church TR, Cruz-Correa M, Figueiredo JC, Goodman M, Kim AS, Robertson DJ, Rothstein R, Shaukat A, Seabrook ME, Summers RW.

N Engl J Med. 2015 Oct 15;373(16):1519-30. doi: 10.1056/NEJMoa1500409.

4.

Race and Prevalence of Large Bowel Polyps Among the Low-Income and Uninsured in South Carolina.

Wallace K, Brandt HM, Bearden JD, Blankenship BF, Caldwell R, Dunn J, Hegedus P, Hoffman BJ, Marsh CH, Marsh WH, Melvin CL, Seabrook ME, Sterba RE, Stinson ML, Thibault A, Berger FG, Alberg AJ.

Dig Dis Sci. 2016 Jan;61(1):265-72. doi: 10.1007/s10620-015-3862-y. Epub 2015 Sep 19.

5.

Transforming growth factors and receptor as potential modifiable pre-neoplastic biomarkers of risk for colorectal neoplasms.

Tu H, Ahearn TU, Daniel CR, Gonzalez-Feliciano AG, Seabrook ME, Bostick RM.

Mol Carcinog. 2015 Sep;54(9):821-30. doi: 10.1002/mc.22152. Epub 2014 Apr 9.

PMID:
24719252
6.

Markers of the APC/β-catenin signaling pathway as potential treatable, preneoplastic biomarkers of risk for colorectal neoplasms.

Ahearn TU, Shaukat A, Flanders WD, Seabrook ME, Bostick RM.

Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):969-79. doi: 10.1158/1055-9965.EPI-12-0126. Epub 2012 Apr 26.

7.

Colorectal mucosal expression of MSH2 as a potential biomarker of risk for colorectal neoplasms.

Sidelnikov E, Bostick RM, Flanders WD, Long Q, Seabrook ME.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2965-73. doi: 10.1158/1055-9965.EPI-09-0519. Epub 2009 Oct 27.

8.

MutL-homolog 1 expression and risk of incident, sporadic colorectal adenoma: search for prospective biomarkers of risk for colorectal cancer.

Sidelnikov E, Bostick RM, Flanders WD, Long Q, Cohen VL, Dash C, Seabrook ME, Fedirko V.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1599-609. doi: 10.1158/1055-9965.EPI-08-0800.

9.

TGF-alpha expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma.

Daniel CR, Bostick RM, Flanders WD, Long Q, Fedirko V, Sidelnikov E, Seabrook ME.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):65-73. doi: 10.1158/1055-9965.EPI-08-0732.

10.

Pyroderma gangrenosum: resolution after treatment for Helicobacter pylori.

Richter JA, Seabrook ME, Shmunes E.

J S C Med Assoc. 2006 Dec;102(10):335-6. No abstract available.

PMID:
17703843

Supplemental Content

Loading ...
Support Center